238 related articles for article (PubMed ID: 10612855)
41. Clinical validation of an automated system for supporting the early diagnosis of melanoma.
Sboner A; Bauer P; Zumiani G; Eccher C; Blanzieri E; Forti S; Cristofolini M
Skin Res Technol; 2004 Aug; 10(3):184-92. PubMed ID: 15225269
[TBL] [Abstract][Full Text] [Related]
42. [Description of French general practitioners' practices regarding long term systemic corticosteroid therapy-associated measures].
Perdoncini-Roux A; Blanchon T; Hanslik T; Lasserre A; Turbelin C; Dorleans Y; Cabane J; Fardet L
Rev Prat; 2009 Oct; 59(8 Suppl):19-24. PubMed ID: 19916281
[TBL] [Abstract][Full Text] [Related]
43. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
[TBL] [Abstract][Full Text] [Related]
44. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
45. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection.
Roetzheim RG; Pal N; van Durme DJ; Wathington D; Ferrante JM; Gonzalez EC; Krischer JP
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):211-8. PubMed ID: 10906640
[TBL] [Abstract][Full Text] [Related]
46. Dermoscopy use by French private practice dermatologists: a nationwide survey.
Moulin C; Poulalhon N; Duru G; Debarbieux S; Dalle S; Thomas L
Br J Dermatol; 2013 Jan; 168(1):74-9. PubMed ID: 22880932
[TBL] [Abstract][Full Text] [Related]
47. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
48. Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.
Rychetnik L; McCaffery K; Morton RL; Thompson JF; Menzies SW; Irwig L
J Surg Oncol; 2013 Apr; 107(5):463-8. PubMed ID: 23090908
[TBL] [Abstract][Full Text] [Related]
49. [Impact of the French consensus guidelines on the management of colonic and rectal cancer: a population-based study].
Borie F; El Nasser M; Herrero A; Gras-Aygon C; Daures JP; Tretarre B;
J Chir (Paris); 2008; 145(3):247-51. PubMed ID: 18772733
[TBL] [Abstract][Full Text] [Related]
50. [Modalities of follow-up after excision of stage I melanoma: practice survey in hospitals].
Couilliet D; Poisson-Salomon AS; Cosquer M; Guillaume JC
Ann Dermatol Venereol; 1995; 122(5):263-6. PubMed ID: 8572463
[No Abstract] [Full Text] [Related]
51. The prescription of opioid analgesics to terminal cancer patients: impact of physicians' general attitudes and contextual factors.
Peretti-Watel P; Bendiane MK; Obadia Y; Favre R; Lapiana JM; Moatti JP;
Palliat Support Care; 2003 Dec; 1(4):345-52. PubMed ID: 16594224
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of dermatology consultations in a prospective multicenter study involving a French teaching hospital].
Maza A; Berbis J; Gaudy-Marqueste C; Morand JJ; Berbis P; Grob JJ; Richard MA
Ann Dermatol Venereol; 2009 Mar; 136(3):241-8. PubMed ID: 19328306
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of patch testing and methodology of dermatologists in the US: results of a cross-sectional survey.
Warshaw EM; Nelson D
Am J Contact Dermat; 2002 Jun; 13(2):53-8. PubMed ID: 12022120
[TBL] [Abstract][Full Text] [Related]
54. A survey of blood transfusion practices of gynecologic oncologists.
Price FV; Kelley JL; Edwards RP; Hasley PB; Amin RM
Gynecol Oncol; 1995 Oct; 59(1):45-50. PubMed ID: 7557614
[TBL] [Abstract][Full Text] [Related]
55. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
[TBL] [Abstract][Full Text] [Related]
56. [Expert consensus on the management of Merkel cell carcinoma].
Guillot B; Boccara O; Mortier L; Bens G; Girard C; Saiag P;
Ann Dermatol Venereol; 2011; 138(6-7):469-74. PubMed ID: 21700067
[TBL] [Abstract][Full Text] [Related]
57. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM).
Lee RT; Hlubocky FJ; Hu JJ; Stafford RS; Daugherty CK
Integr Cancer Ther; 2008 Jun; 7(2):70-5. PubMed ID: 18505899
[TBL] [Abstract][Full Text] [Related]
58. Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in France.
Caudron A; Chaby G; Dadban A; Andrejak C; Dhaille F; Bagot M; Lok C
Eur J Dermatol; 2010; 20(6):778-84. PubMed ID: 20959274
[TBL] [Abstract][Full Text] [Related]
59. Communication about family members' risk of melanoma: self-reported practices of dermatologists in the United States.
Oliveria SA; Heneghan MK; Halpern AC; Hay JL; Geller AC
Arch Dermatol; 2012 May; 148(5):621-7. PubMed ID: 22250188
[TBL] [Abstract][Full Text] [Related]
60. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions.
Hauschild A; Chen SC; Weichenthal M; Blum A; King HC; Goldsmith J; Scharfstein D; Gutkowicz-Krusin D
J Dtsch Dermatol Ges; 2014 Jul; 12(7):606-14. PubMed ID: 24944011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
